Locations:
Search IconSearch

Diagnosis and Treatment of Refractory Pelvic Pain

Laparoscopic surgery provides relief for teenage patient with adenomyoma and endometriosis

adenomyoma

When medical therapy provided minimal relief for a 16-year-old with chronic pelvic pain and dysmenorrhea, the patient’s gynecologist referred her to experts in Cleveland Clinic’s Ob/Gyn & Women’s Health Institute. After a multidisciplinary team discovered the patient had a juvenile cystic adenomyoma and concomitant endometriosis, she elected to undergo laparoscopic surgery.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“This case is interesting because of the patient’s age and the pathology,” says Angelina Carey-Love, MD, a physician in the Department of Obstetrics and Gynecology. “Focal adenomyosis is fairly uncommon, especially in combination with endometriosis. Medical management is an option, but it doesn’t always work. Surgery is indicated in certain circumstances.”

Dr. Carey-Love and three colleagues published a video presentation of surgical techniques for excision of juvenile cystic adenomyoma in the American Journal of Obstetrics & Gynecology, as well as on YouTube.

A team approach

The patient’s gynecologist prescribed birth control pills, a common first line of therapy, when the young woman originally complained of pain accompanying her periods.

“A lot of patients have primary dysmenorrhea, but there can be secondary causes, including adenomyosis, endometriosis, congenital anomalies, cysts and pelvic inflammatory disease,” says Dr. Carey-Love.

The pain persisted for 18 months, so the gynecologist ordered an ultrasound, which revealed a 2.4 cm lesion in the left adnexa. The gynecologist performed a diagnostic laparoscopy, but couldn’t discern the lesion internally. So the patient was referred to reproductive, endocrinology and infertility (REI) specialists at Cleveland Clinic.

The REI physicians started the patient on leuprolide acetate, a gonadotropin-releasing hormone (GnRH) medicine. However, the pain continued and subsequent imaging studies revealed a T2-hypointense round lesion in the posterior myometrium, now smaller, measuring 1.1 cm.

Advertisement

“Since the patient was still in pain, she was offered and desired surgical management,” says Dr. Carey-Love, who is part of the Minimally Invasive Gynecologic Surgery (MIGS) team. The patient was taken off of leuprolide acetate, which had the side effect of shrinking the lesion, so it would grow and be easier to locate during surgery.

Three months later, teams from MIGS and REI collaborated on the 2 ½-hour, minimally invasive surgery. They performed a hysteroscopy to fully examine the cervix and uterus, then laparoscopically resected the adenomyoma and excised pelvic endometriosis lesions. The patient was placed on hormonal suppression post-operatively, and she is doing well, with only minor cramping during her menses. “A multidisciplinary approach was essential to successful diagnosis and treatment,” says Dr. Carey-Love. “Healthcare providers from REI, MIGS and medical imaging all worked together.”

Four surgical techniques

Dr. Carey-Love shared surgical techniques for excision of adenomyomas in her video presentation to create awareness about the condition and encourage other physicians in MIGS to consider the procedure when appropriate.

“Surgeons don’t need to be at a large tertiary center. Anyone who is confident in their laparoscopic skills and pelvic anatomy can perform this procedure,” she says. “If they follow the critical steps, then they can successfully treat patients.”

Dr. Carey-Love highlights four key points about the technique:

  • Maximize visualization. “It’s important to maximize visualization, with use of a uterine manipulator and temporary oophoropexy when indicated, to make sure you can adequately see the lesion for better excision and outcomes,” she says.
  • Optimize hemostasis. “These lesions are within the muscle of the uterus, so they can bleed,” says Dr. Carey-Love. Temporary uterine artery ligation and control of collateral blood vessels can help optimize hemostasis.
  • Complete ureterolysis. “The ureter is a vital structure that must be considered during gynecologic surgery to avoid injury,” she says.
  • Perform meticulous enucleation of the adenomyoma. “Make sure you get the entire lesion out to limit disease recurrence,” says Dr. Carey-Love.

Advertisement

She also shares a message with gynecology peers about pain. “Unfortunately, pain with menses is normalized, and many patients get into their 30s and 40s living unnecessarily with pain,” says Dr. Carey-Love. “If you are treating a patient with persistent pain, don’t be afraid to bring other physicians on board to figure it out. We need to change the way we think about pain.”

Advertisement

Related Articles

physicians during surgical coaching training
Building a Coaching Framework for Surgeons

A Q&A with Cara King, DO, MS, on the upleveling power of coaching

woman doing yoga
Rethinking Activity After Pelvic Prolapse Surgery

New guidelines let the patients steer the process

celiac disease
October 24, 2023/Digestive/Research
Women’s Health Disorders Found More Frequently Among Individuals With Celiac Disease

Findings reinforce the importance of multidisciplinary care

Contraception counseling
Contraceptive Counseling: Telehealth Versus In-Person

Mode of delivery does not affect patient satisfaction

Uterus-Transplant 650×450
What You Need to Know About Intraoperative Uterine Perforations

Guidance for complications that occur during procedures

Paternalism in women's health
Commentary: Paternalism in Ob/Gyn Practice

How we create obstacles for sexual, reproductive and menopausal healthcare despite our best intentions

Pelvic prolapse
Native-Tissue Pelvic Prolapse Surgery Improves Sexual Function

Study indicates patients can have confidence about potential outcomes

contraception
Update on Current Contraceptive Options

A case-based discussion of efficacy, eligibility and use

Ad